SCHEMBL6806719

SCHEMBL6806719

CC(C)(C)[Si](C)(C)Oc1ccc([C@H]2CC[C@H](N(C(=O)O)c3ccccc3)CC2)c(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
TRPM8 Q7Z2W7 3/20 0.35
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA9 Q16790 2/20 0.33
CHRM2 P08172 2/20 0.33
CHRM3 P20309 2/20 0.33
OPRD1 P41143 3/20 0.32
OPRM1 P35372 3/20 0.32
SIGMAR1 Q99720 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
MITF O75030 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RAB9A P51151 1/20 0.32
PAX8 Q06710 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6806711 1.00 HSP90AA1 (0.35) HSP90AA1HSP90AB1TRPM8CA12CA1
SCHEMBL7063409 0.82 HSP90AA1 (0.35) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL7063406 0.82 HSP90AA1 (0.35) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL6434340 0.80 CA12 (0.39) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL6433944 0.79 CA12 (0.39) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL6499011 0.79 CA12 (0.39) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL6434515 0.79 CA12 (0.39) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL6433948 0.79 CA12 (0.39) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL7062211 0.79 MRGPRX4 (0.35) HSP90AA1HSP90AB1TRPM8MEN1KMT2A
SCHEMBL7064802 0.79 MRGPRX4 (0.35) HSP90AA1HSP90AB1TRPM8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6797731-B2 USE AS SKIN LIGHTENING AGENTS PFIZER INC. 2004-09-28 US disclosed
US-20030190298-A1 Resorcinol derivatives BRADLEY STUART E (GB) 2003-10-09 US disclosed
US-6541473-B2 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example WARNER LAMBERT COMPANY 2003-04-01 US disclosed
US-20020137961-A1 Resorcinol derivatives PFIZER INC. 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030190298-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 HSP90AA1 1266/4885HSP90AB1 1208/4885TRPM8 2024/4885
US-20020137961-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 HSP90AA1 1266/4885HSP90AB1 1208/4885TRPM8 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.